Schikan Johannes Gerardus Christiaan Petrus 4

What Happened
Director Johannes Gerardus Christiaan Petrus Schikan sold a total of 7,100 Pharvaris (PHVS) shares in open-market/private sales. The filing reports 7,000 shares sold on 2026-04-22 at $30.05 (reported $210,379) and 100 shares sold on 2026-04-23 at $30.03 ($3,003), for combined proceeds of about $213,382. These were sales (not purchases) and therefore are generally seen as routine dispositions rather than a bullish signal.

Key Details

• Transaction dates and prices: 2026-04-22 — 7,000 shares at $30.05; 2026-04-23 — 100 shares at $30.03. Footnote indicates multiple trades at prices ranging $30.00–$30.13.
• Total shares sold: 7,100; total proceeds reported: ~$213,382.
• Shares owned after transaction: not disclosed in the provided filing.
• Notable footnotes: F1 — sale was a scheduled exercise and sale under a pre-established 10b5-1 trading plan; F2 — shares were sold in multiple transactions at prices between $30 and $30.13.
• Filing: Form 4 filed 2026-04-24 reporting transactions dated 2026-04-22/23; this filing appears timely.

Context

• Sales executed under a 10b5-1 plan are pre-scheduled and commonly used by insiders to avoid trading based on nonpublic information; they do not necessarily indicate a change in the insider’s view of the company.
• For retail investors, purchases tend to be more informative about insider confidence; routine sales (especially under 10b5-1 plans) are often for diversification or tax/liquidity reasons.